Reversal of monoarthritis-induced affective disorders by diclofenac in rats

Anesthesiology

Volumn 120, Issue 6, 2014, Pages 1476-1490

  Borges, Gisela ^a,b,c   Neto, Fani ^b,c   Mico, Juan Antonio ^a,d   Berrocoso, Esther ^a,d  

^a UNIVERSITY OF CÁDIZ   (Spain)

^b University of Porto   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; FREUND ADJUVANT; MITOGEN ACTIVATED PROTEIN KINASE 1;

ALLODYNIA; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DEPRESSION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HYPERALGESIA; INFLAMMATION; LOCUS CERULEUS; MALE; MONARTHRITIS; MOOD DISORDER; NONHUMAN; PAIN THRESHOLD; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SPINAL CORD;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; DICLOFENAC; MALE; MAP KINASE SIGNALING SYSTEM; MOOD DISORDERS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84901623586     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000177     Document Type: Article

References (46)

1. Phillips K, Clauw DJ: Central pain mechanisms in the rheumatic diseases: Future directions. Arthritis Rheum 2013; 65:291-302
2. Price DD: Psychological and neural mechanisms of the affective dimension of pain. Science 2000; 288:1769-72
3. Dersh J, Polatin PB, Gatchel RJ: Chronic pain and psychopathology: Research findings and theoretical considerations. Psychosom Med 2002; 64:773-86
4. Holzberg AD, Robinson ME, Geisser ME, Gremillion HA: The effects of depression and chronic pain on psychosocial and physical functioning. Clin J Pain 1996; 12:118-25
5. Pisetsky DS, St Clair EW: Progress in the treatment of rheumatoid arthritis. JAMA 2001; 286:2787-90
6. Stanos SP: Topical agents for the management of musculoskeletal pain. J Pain Symptom Manage 2007; 33:342-55
7. Itoi K, Sugimoto N: The brainstem noradrenergic systems in stress, anxiety and depression. J Neuroendocrinol 2010; 22:355-61
8. Ennis M, Aston-Jones G, Shiekhattar R: Activation of locus coeruleus neurons by nucleus paragigantocellularis or noxious sensory stimulation is mediated by intracoerulear excitatory amino acid neurotransmission. Brain Res 1992; 598:185-95
9. Cao H, Gao YJ, Ren WH, Li TT, Duan KZ, Cui YH, Cao XH, Zhao ZQ, Ji RR, Zhang YQ: Activation of extracellular signal-regulated kinase in the anterior cingulate cortex contributes to the induction and expression of affective pain. J Neurosci 2009; 29:3307-21
10. Dai RP, Li CQ, Zhang JW, Li F, Shi XD, Zhang JY, Zhou XF: Biphasic activation of extracellular signal-regulated kinase in anterior cingulate cortex distinctly regulates the development of pain-related anxiety and mechanical hypersensitivity in rats after incision. Anesthesi ology 2011; 115:604-13
11. Rainville P, Duncan GH, Price DD, Carrier B, Bushnell MC: Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 1997; 277:968-71
12. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, Kosslyn SM, Rose RM, Cohen JD: Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 2004; 303:1162-7
13. Wei F, Zhuo M: Activation of Erk in the anterior cingulate cortex during the induction and expression of chronic pain. Mol Pain 2008; 4:28
14. Gao YJ, Ji RR: c-Fos and pERK, which is a better marker for neuronal activation and central sensitization after noxious stimulation and tissue injury? Open Pain J 2009; 2:11-7
15. Kingwell K: Pain: MAPK inhibitor shows promise in clinical trial for neuropathic pain. Nat Rev Neurol 2011; 7:360
16. Ji RR, Kawasaki Y, Zhuang ZY, Wen YR, Zhang YQ: Protein kinases as potential targets for the treatment of pathological pain. Handb Exp Pharmacol 2007:359-89
17. Zimmermann M: Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16:109-10
18. Butler SH, Godefroy F, Besson JM, Weil-Fugazza J: A limited arthritic model for chronic pain studies in the rat. Pain 1992; 48:73-81
19. Castro-Lopes JM, Tavares I, Tölle TR, Coito A, Coimbra A: Increase in GABAergic cells and GABA levels in the spinal cord in unilateral inflammation of the hindlimb in the rat. Eur J Neurosci 1992; 4:296-301
20. Butler SH, Weil-Fugazza J: The foot-bend procedure as test of nociception for chronic studies in a model of monoarthritis in the rat. Pharmacol Commun 1994; 4:327-34
21. Randall LO, Selitto JJ: A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 1957; 111:409-19
22. Njung'e K, Handley SL: Evaluation of marble-burying behavior as a model of anxiety. Pharmacol Biochem Behav 1991; 38:63-7
23. Detke MJ, Rickels M, Lucki I: Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 1995; 121:66-72
24. Sekiguchi M, Shirasaka M, Konno S, Kikuchi S: Analgesic effect of percutaneously absorbed non-steroidal anti-inflammatory drugs: An experimental study in a rat acute inflammation model. BMC Musculoskelet Disord 2008; 9:15
25. Narita M, Kaneko C, Miyoshi K, Nagumo Y, Kuzumaki N, Nakajima M, Nanjo K, Matsuzawa K, Yamazaki M, Suzuki T: Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology 2006; 31:739-50
26. Alba-Delgado C, Llorca-Torralba M, Horrillo I, Ortega JE, Mico JA, Sánchez-Blázquez P, Meana JJ, Berrocoso E: Chronic pain leads to concomitant noradrenergic impairment and mood disorders. Biol Psychiatry 2013; 73:54-62
27. Parent AJ, Beaudet N, Beaudry H, Bergeron J, Bérubé P, Drolet G, Sarret P, Gendron L: Increased anxiety-like behaviors in rats experiencing chronic inflammatory pain. Behav Brain Res 2012; 229:160-7
28. Axford J, Butt A, Heron C, Hammond J, Morgan J, Alavi A, Bolton J, Bland M: Prevalence of anxiety and depression in osteoarthritis: Use of the Hospital Anxiety and Depression Scale as a screening tool. Clin Rheumatol 2010; 29:1277-83
29. Goldenberg DL: The interface of pain and mood disturbances in the rheumatic diseases. Semin Arthritis Rheum 2010; 40:15-31
30. Yalcin I, Bohren Y, Waltisperger E, Sage-Ciocca D, Yin JC, Freund-Mercier MJ, Barrot M: A time-dependent history of mood disorders in a murine model of neuropathic pain. Biol Psychiatry 2011; 70:946-53
31. Imbe H, Senba E, Kimura A, Donishi T, Yokoi I, Kaneoke Y: Activation of mitogen-activated protein kinase in descending pain modulatory system. J Signal Transduct 2011; 2011:468061
32. Ji RR, Gereau RW IV, Malcangio M, Strichartz GR: MAP kinase and pain. Brain Res Rev 2009; 60:135-48
33. Einat H, Yuan P, Gould TD, Li J, Du J, Zhang L, Manji HK, Chen G: The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 2003; 23:7311-6
34. Qi X, Lin W, Wang D, Pan Y, Wang W, Sun M: A role for the extracellular signal-regulated kinase signal pathway in depressive-like behavior. Behav Brain Res 2009; 199:203-9
35. Zhong XL, Wei R, Zhou P, Luo YW, Wang XQ, Duan J, Bi FF, Zhang JY, Li CQ, Dai RP, Li F: Activation of anterior cingulate cortex extracellular signal-regulated kinase-1 and-2 (ERK1/2) regulates acetic acid-induced, pain-related anxiety in adult female mice. Acta Histochem Cytochem 2012; 45:219-25
36. Cruz CD, Neto FL, Castro-Lopes J, McMahon SB, Cruz F: Inhibition of ERK phosphorylation decreases nociceptive behaviour in monoarthritic rats. Pain 2005; 116:411-9
37. Schadrack J, Neto FL, Ableitner A, Castro-Lopes JM, Willoch F, Bartenstein P, Zieglgänsberger W, Tölle TR: Metabolic activity changes in the rat spinal cord during adjuvant monoarthritis. Neuroscience 1999; 94:595-605
38. Alba-Delgado C, Borges G, Sánchez-Blázquez P, Ortega JE, Horrillo I, Mico JA, Meana JJ, Neto F, Berrocoso E: The function of alpha-2-adrenoceptors in the rat locus coeruleus is preserved in the chronic constriction injury model of neuropathic pain. Psychopharmacology (Berl) 2012; 221:53-65
39. Borges GS, Berrocoso E, Ortega-Alvaro A, Mico JA, Neto FL: Extracellular signal-regulated kinase activation in the chronic constriction injury model of neuropathic pain in anaesthetized rats. Eur J Pain 2013; 17:35-45
40. Imbe H, Okamoto K, Donishi T, Kawai S, Enoki K, Senba E, Kimura A: Activation of ERK in the locus coeruleus following acute noxious stimulation. Brain Res 2009; 1263:50-7
41. Dawane JS, Pandit VA, Rajopadhye BD: Experimental evaluation of anti-inflammatory effect of topical application of entada phaseoloides seeds as paste and ointment. N Am J Med Sci 2011; 3:513-7
42. Dong XD, Svensson P, Cairns BE: The analgesic action of topical diclofenac may be mediated through peripheral NMDA receptor antagonism. Pain 2009; 147:36-45
43. McCarberg BH, Argoff CE: Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury. Int J Clin Pract 2010; 64:1546-53
44. Lionberger DR, Brennan MJ: Topical nonsteroidal anti-inflammatory drugs for the treatment of pain due to soft tissue injury: Diclofenac epolamine topical patch. J Pain Res 2010; 3:223-33
45. Tse S, Powell KD, Maclennan SJ, Moorman AR, Paterson C, Bell RR: Skin permeability and pharmacokinetics of diclofenac epolamine administered by dermal patch in Yorkshire-Landrace pigs. J Pain Res 2012; 5:401-8
46. Gwilym SE, Filippini N, Douaud G, Carr AJ, Tracey I: Thalamic atrophy associated with painful osteoarthritis of the hip is reversible after arthroplasty: A longitudinal voxel-based morphometric study. Arthritis Rheum 2010; 62:2930-40